Table 3. Top public-private partnerships in 2012 by value. Two of the five largest 2012 public-private partnerships (PPPs) without direct government support were valued at $100 million or more. PPPs that include grants, awards and/or other types of direct funding support from national governments and government institutions are included in the 2012 list but ranked separately from those without such support. Only 128 of the 387 PPPs reported in 2012 had disclosed dollar amounts. Excludes deals that only involved IP transfer.

Source: BioCentury Archives

Companies

Institutions

Disclosed
value
($M)

PPPs without direct support from national governments and/or government institutions

Aeras

Bill & Melinda Gates Foundation

220

BioMotiv LLC

University Hospitals

100

Merck & Co. Inc. (NYSE:MRK)

California Institute for Biomedical Research

90

Pfizer Inc. (NYSE:PFE)

Cystic Fibrosis Foundation

58

Shire plc (LSE:SHP; NASDAQ:SHPG)

Fondazione Telethon

22

PPPs with direct support from national governments and/or government institutions

Abbott Laboratories (NYSE:ABT); AstraZeneca plc (LSE:AZN; NYSE:AZN); Bayer AG (Xetra:BAYN); Becton Dickinson and Co. (NYSE:BDX); Bristol-Myers Squibb Co. (NYSE:BMY); Eisai Co. Ltd. (Tokyo:4523; Osaka:4523); Gilead Sciences Inc. (NASDAQ:GILD); GlaxoSmithKline plc (LSE:GSK; NYSE:GSK); Johnson &
Johnson (NYSE:JNJ); Merck & Co.; Merck KGaA (Xetra:MRK); Novartis AG (NYSE:NVS; SIX:NOVN); Pfizer; Sanofi (Euronext:SAN; NYSE:SNY)

Bill & Melinda Gates Foundation; Drugs for Neglected Diseases initiative; Lions Clubs International Foundation; Mundo Sano; The Children's Investment Fund Foundation; The World Bank; United Arab Emirates government; U.K. government; U.S. government; World Health Organization

>785

Emergent BioSolutions Inc. (NYSE:EBS); GlaxoSmithKline; Kalon Biotherapeutics LLC; Lonza Group Ltd. (SIX:LONN); Novartis

The Texas A&M University System; U.S. Department of Health and Human Services

400

AstraZeneca; GlaxoSmithKline

Innovative Medicines Initiative

281.6A

None yet

U.S. Department of Defense; U.S. Department of Veterans Affairs

108

Not applicable

Duke University; NIH; The Scripps Research Institute

31B

AReflects current budget, but program is estimated to utilize up to €600 million ($755.3 million) over the next 7 years. BReflects initial funding, but program is estimated to receive $186 million or more over the next 6 years.